Accompanied by downregulation of CD133/ABCG2 and upregulation of glial fibrillary acidic protein, bELE was shown to decrease the formation of spheres and inhibit the proliferation of glioma stem cells both in vitro and in vivo [47]. The gene discussed is GFAP; the disease is central nervous system cancer.